Cargando…
Pathophysiological mechanisms explaining poor clinical outcome of older cancer patients with low skeletal muscle mass
Low skeletal muscle mass is highly prevalent in older cancer patients and affects 5% to 89% depending on the type and stage of cancer. Low skeletal muscle mass is associated with poor clinical outcomes such as post‐operative complications, chemotherapy toxicity and mortality in older cancer patients...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757176/ https://www.ncbi.nlm.nih.gov/pubmed/32478975 http://dx.doi.org/10.1111/apha.13516 |